Back to School: How biopharma can reboot drug development. Access exclusive analysis here

TNKase tenecteplase update

In early 2008, Boehringer will begin the open-label, international STREAM trial in 2,000

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE